Evidence map›Paper›PMID 34274108›Full record

Trial reportBiological psychiatry2021

Deep Transcranial Magnetic Stimulation Combined With Brief Exposure for Posttraumatic Stress Disorder: A Prospective Multisite Randomized Trial.

Moshe Isserles, Aron Tendler, Yiftach Roth, Alexander Bystritsky, Daniel M Blumberger, Herbert Ward, David Feifel, Laura Viner, Walter Duffy, Joseph Zohar and 15 more

Abstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Biological psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 2 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 2 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. A Critical Time Window of Neocortex Modulation for Remote Fear Memory in Rats and Humans.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Review
  10. Article
  11. Advancing TMS for PTSD - From networks to individuals.Transcranial magnetic stimulation (2024) · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Neuromodulation of Fear and Anxiety Circuits.Current topics in behavioral neurosciences · 2025
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 17 institutions in 4 countries.

Moshe IsserlesDepartment of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Temerty Centre for Therapeutic Brain Intervention, University of Toronto, Toronto, Ontario, Canada; Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada. Electronic address: moshayi@yahoo.com.
Aron TendlerAdvanced Mental Health Care Inc., Palm Beach/Royal Palm Beach/Juno Beach, Florida.
Yiftach RothDepartment of Life Sciences, Ben Gurion University, Beer Sheva, Israel; Zlotowski Center for Neuroscience, Ben Gurion University, Beer Sheva, Israel.
Alexander BystritskyCalNeuro Research Group, Los Angeles, California.
Daniel M BlumbergerTemerty Centre for Therapeutic Brain Intervention, University of Toronto, Toronto, Ontario, Canada; Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada.
Herbert WardUniversity of Florida Health Adult Psychiatry, Gainesville, Florida.
David FeifelKadima Neuropsychiatry Institute, San Diego, California.
Laura VinerYellowbrick Center for Clinical Neuroscience, Evanston, Illinois.
Walter DuffyAlivation Health, Lincoln, Nebraska.
Joseph ZoharSheba Medical Center, Psychiatry A and Anxiety and Obsessive Compulsive Clinic, Ramat Gan, Israel.
Corey J KellerDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California; VA Palo Alto Health Care System, Palo Alto, California.
Mahendra T BhatiDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California.
Amit EtkinDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California; Wu Tsai Neurosciences Institute, Stanford University, Stanford, California; Alto Neuroscience, Inc., Los Altos, California.
Mark S GeorgeDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina; Department of Psychiatry Research, Ralph H. Johnson VA Medical Center, Charleston, South Carolina.
Igor FilipcicDepartment of Psychiatry and Psychological Medicine, Sveti Ivan Psychiatric Hospital, Zagreb, Croatia.
Kyle LapidusTMS Hope Center of Long Island, Port Jefferson, New York.
Leah CasutoLindner Center of Hope, Mason, Ohio.
Sandeep VaishnaviMindPath Care Center Interventional Psychiatry and Clinical Research Institute, Raleigh, North Carolina.
Ahava SteinA. Stein Regulatory Affairs Consulting Ltd., Kfar Saba, Israel.
Lisa DeutschBiostatistics Statistical Consulting Ltd., Maccabim, Israel.
Frederic DeutschBiostatistics Statistical Consulting Ltd., Maccabim, Israel.
Oscar MoralesMcLean Hospital, Harvard Medical School, Belmont, Massachusetts.
Zafiris J DaskalakisDepartment of Psychiatry, University of California San Diego Health, La Jolla, California.
Abraham ZangenDepartment of Life Sciences, Ben Gurion University, Beer Sheva, Israel; Zlotowski Center for Neuroscience, Ben Gurion University, Beer Sheva, Israel.
Kerry J ResslerMcLean Hospital, Harvard Medical School, Belmont, Massachusetts. Electronic address: kressler@mclean.harvard.edu.
Ben-Gurion University of the Negev · ILCentre for Addiction and Mental Health · CAHarvard University · USMaccabi Healthcare Services · ILAdvanced Mental Health Care · USAlivation (United States) · USClinical Research Institute · USLindner Center of HOPE · USMedical University of South Carolina · USNeuropsychiatric Research Institute · USNeurosciences Institute · USPsychiatric Hospital Sveti Ivan · HRSheba Medical Center · ILStanford University · USUniversity of California San Diego · USUniversity of Florida Health · USVA Palo Alto Health Care System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPosttraumatic stress disorder (PTSD) is both prevalent and debilitating. While deep transcranial magnetic stimulation (dTMS) has shown preliminary efficacy, exposure therapy remains the most efficacious, though limited, treatment in PTSD. The medial prefrontal cortex (mPFC) is implicated in extinction learning, suggesting that concurrent mPFC stimulation may enhance exposure therapy. In this randomized controlled multicenter trial, the efficacy and safety of mPFC dTMS combined with a brief exposure procedure were studied in patients with PTSD.

methodsImmediately following exposure to their trauma narrative, 125 outpatients were randomly assigned to receive dTMS or sham. Twelve sessions were administered over 4 weeks, with a primary end point of change in 5-week Clinician-Administered PTSD Scale for DSM-5 score. This clinical study did not include biological markers.

resultsClinician-Administered PTSD Scale for DSM-5 score improved significantly in both groups at 5 weeks, though the improvement was smaller in the dTMS group (16.32) compared with the sham group (20.52; p = .027). At 9 weeks, improvement continued in Clinician-Administered PTSD Scale for DSM-5 score in both groups but remained smaller in dTMS (19.0) versus sham (24.4; p = .024).

conclusionsBoth groups showed significant PTSD symptom improvement, possibly from the brief script-driven imagery exposure. While our design was unable to rule out placebo effects, the magnitude and durability of improvement suggest that repeated ultrabrief exposure therapy alone may be an effective treatment for PTSD, warranting additional study. The surprising and unexpected effect in the dTMS group also suggests that repeated mPFC stimulation with the H7 coil may interfere with trauma memory-mediated extinction. Our results provide new insight for dTMS approaches for possible future avenues to treat PTSD.

Indexed as

Implosive TherapyStress Disorders, Post-TraumaticDouble-Blind MethodHumansProspective StudiesTranscranial Magnetic StimulationTreatment OutcomeDeep TMSExposure therapymPFCPosttraumatic stress disorderPTSDScript-driven imagery

Identifiers

PMID34274108
OpenAlexW3159413402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.